Chembio Diagnostics Receives CE Mark for Point-of-Care Diagnostic Test Developed in Collaboration with AstraZeneca
Chembio Diagnostics, Inc. (CEMI)
Last chembio diagnostics, inc. earnings: 3/12 04:07 pm
Check Earnings Report
US:NASDAQ Investor Relations:
chembio.com/investors/investor-relations
Company Research
Source: GlobeNewswire
MEDFORD, N.Y., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has received a CE mark for its diagnostic test developed in collaboration with AstraZeneca, a global biopharmaceutical company. Chembio and AstraZeneca have collaborated to develop a quantitative diagnostic test to detect an undisclosed biomarker, using Chembio’s patented DPP® platform. The CE marked DPP® System, which includes the new DPP® test and DPP® Micro Reader, provides quantitative results in ten minutes from a small drop of fingertip or venous blood. “We are pleased to receive the CE mark within 12 months of announcing the collaboration with AstraZeneca. This achievement highlights both our technical expertise and the speed at which we can bring tests to market,” said John Sperzel, Chembio’s Chief Executive Officer. “We look forward to working closely with AstraZeneca in pursuit of ad
Show less
Read more
Impact Snapshot
Event Time:
CEMI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CEMI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CEMI alerts
High impacting Chembio Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics